Table 1.
Clinical variables in prostate cancer and non-prostate cancer subjects in two PSA ranges.
Table 2.
Diagnostic accuracy of total PSA and %fPSA in predicting prostate cancer and high-grade prostate cancer stratified by age decades.
Fig 1.
ROC curves of %fPSA and PSA for any PCa.
ROC curves of %fPSA and PSA in predicting any prostate cancer for patients aged (A) 50–59 years; (B) 60–69 years; (C) 70–79 years; and (D) 80–89 years with a PSA level of 4.0–10.0 ng/ml.
Fig 2.
ROC curves of %fPSA and PSA for high-grade PCa.
ROC curves of %fPSA and PSA in predicting high-grade prostate cancer for patients aged (A) 50–59 years; (B) 60–69 years; (C) 70–79 years; and (D) 80–89 years with a PSA level of 4.0–10.0 ng/ml.
Table 3.
Application of age-specific %fPSA cutoffs to reduce unnecessary biopsies in different age decades.